19:05:38 EDT Mon 01 Jun 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Delphx Capital Markets Inc
Symbol DELX
Shares Issued 226,560,183
Close 2026-06-01 C$ 0.03
Market Cap C$ 6,796,805
Recent Sedar+ Documents

Delphx closes $125,000 convertible debenture offering

2026-06-01 17:56 ET - News Release

Mr. George Wentworth reports

DELPHX ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE

Delphx Capital Markets Inc. has closed its non-brokered convertible debenture private placement financing consisting of a $125,000 principal amount convertible debenture. The debenture will bear interest at a rate of 8 per cent per annum, mature one year from the date of issuance, being May 29, 2027, and will be convertible into up to 2.5 million common shares of Delphx at a conversion price of five cents per share.

The offering is subject to the final approval of the TSX Venture Exchange. The debenture and the securities issuable upon conversion thereof are subject to a hold period of four months plus one day from the date of issuance.

Delphx intends to use the net proceeds from the offering in connection with working capital/corporate overhead.

About Delphx Capital Markets Inc.

Delphx is a technology and financial service company focused on developing and distributing the next generation of structured products. Through its special-purpose vehicle Quantem LLC, the company enables broker dealers to offer new private placement securities that provide for both fixed-income and cryptocurrency solutions. The new Delphx securities will enable dealers and their qualified institutional investors accounts to competitively structure, sell and make markets in:

  • Collateralized put options that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
  • Collateralized reference notes that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by U.S. Bank. CPOs and CRNs are proprietary products created and owned by Delphx Capital Markets.

© 2026 Canjex Publishing Ltd. All rights reserved.